MARLO MILLER: Open Payments
NPI 1578572970 · AVON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,025 in 112 payments from 18 companies in 2025. Trend: 2023 $1,685 · 2024 $1,610 · 2025 $2,025
Food & beverage: $2,025
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $434 |
| Madrigal Pharmaceuticals | 32 | $359 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $276 |
| Janssen Biotech, Inc. | 5 | $166 |
| Ardelyx, Inc. | 7 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $103 |
| GENZYME CORPORATION | 2 | $80 |
| PFIZER INC. | 4 | $73 |
| Aimmune Therapeutics, Inc. | 3 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $69 |
Products named: REZDIFFRA, RINVOQ, ENTYVIO, TREMFYA, DUPIXENT, IBSRELA, XIFAXAN, LINZESS.
Industry payments across IN — which companies pay providers there.
